Home Tags Pharmaceutical Industry
Tag: Pharmaceutical Industry
Evidence is mounting that psychedelic drugs can help treat diseases. Here are the most promising uses.
There's been a resurgence of interest in psychedelic drugs' potential to treat conditions like depression. Research is beginning to yield new treatments.
Dispensed: How health insurance startups fared at the start of 2019, Impossible Foods’ big burger change, and a look at uBiome’s board
Welcome to Dispensed, our weekly dispatch of healthcare, biotech, and pharma news from Business Insider.
Dispensed: Tim Ferriss is backing psychedelic research, how to change your business model as told by pitch decks, and how much money healthcare CEOs m...
Welcome to Dispensed, Business Insider's weekly newsletter giving you a dose of pharma, biotech, and healthcare news.
Healthcare CEOs take home some of the biggest pay packages in the world. Here’s what the industry’s top executives earned last year.
We took a look at the compensation packages of the leaders overseeing some of the biggest healthcare companies.
Everybody is talking about the high cost of prescription drugs. Here’s who’s actually responsible for the prices you pay.
Here's a look at all the companies involved in paying for a medication and why that can lead to higher prices.
A drugmaker just released a half-price version of a life-saving diabetes medication in a bet that a lower price tag will help it escape the political ...
Eli Lilly plans to make a generic version of its life-saving diabetes medication Humalog and sell it for half the price of the branded drug.
Pharma companies want the government to do something about high drug prices, so long as it’s not forcing them to lower their drug prices
Pharmaceutical executives seemed to reach a consensus that it'll take government action to solve the conundrum of how we get to lower drug prices.
The CEO of a $210 billion pharma company says that US drug prices are working against patients. One chart explains why.
The CEO of the French drugmaker Sanofi provided an unusual look behind the curtain of US drug prices.
Roche is set to buy gene therapy firm Spark Therapeutics for about $4.8 billion. Spark's stock more than doubled in premarket trading.
Welcome to Dispensed: A weekly dose of pharma, biotech, and healthcare news.